Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Document Type
Article
Publication Date
4-1-2020
Publication Title
J Immunother Cancer
Keywords
Betacoronavirus; Coronavirus Infections; Drug Approval; Humans; Immunologic Factors; Immunotherapy; Inflammation; Interleukin-6; Neoplasms; Pandemics; Pneumonia, Viral; Receptors, Interleukin-6; 2019-nCoV
Clinical Institute
Cancer
Department
Oncology
Department
Infectious Diseases
Recommended Citation
Ascierto, Paolo Antonio; Fox, Bernard A; Urba, Walter; Anderson, Ana Carrizosa; Atkins, Michael B; Borden, Ernest C; Brahmer, Julie; Butterfield, Lisa H; Cesano, Alessandra; Chen, Daniel; de Gruijl, Tanja; Dillman, Robert O; Drake, Charles G; Emens, Leisha A; Gajewski, Thomas F; Gulley, James L; Stephen Hodi, F; Hwu, Patrick; Kaufman, David; Kaufman, Howard; Lotze, Michael; McNeel, Douglas G; Margolin, Kim; Marincola, Francesco; Mastrangelo, Michael J; Maus, Marcela V; Parkinson, David R; Romero, Pedro J; Sondel, Paul M; Spranger, Stefani; Sznol, Mario; Weiner, George J; Wiggington, Jon M; and Weber, Jeffrey S, "Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19." (2020). Articles, Abstracts, and Reports. 3040.
https://digitalcommons.providence.org/publications/3040
